RMDI
GILD icon

R.M. Davis Inc’s Gilead Sciences GILD Stock Holding History

R.M. Davis Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
2,222
+48
+2% +$6.32K ﹤0.01% 250
2026
Q1 		$303K Buy
2,174
+450
+26% +$63K 0.01% 238
2025
Q4 		$212K Sell
1,724
-170
-9% -$20.7K ﹤0.01% 267
2025
Q3 		$210K Buy
+1,894
New +$215K ﹤0.01% 267
2021
Q1 		– Sell
-3,721
Closed -$217K – 266
2020
Q4 		$217K Buy
3,721
+391
+12% +$23.6K 0.01% 254
2020
Q3 		$210K Sell
3,330
-300
-8% -$20.8K 0.01% 230
2020
Q2 		$279K Buy
3,630
+598
+20% +$45.8K 0.01% 194
2020
Q1 		$227K Sell
3,032
-2,000
-40% -$138K 0.01% 203
2019
Q4 		$327K Buy
5,032
+370
+8% +$24.1K 0.01% 191
2019
Q3 		$295K Buy
+4,662
New +$305K 0.01% 194
2018
Q2 		– Sell
-9,757
Closed -$736K – 229
2018
Q1 		$736K Sell
9,757
-2,866
-23% -$228K 0.03% 148
2017
Q4 		$904K Sell
12,623
-5,832
-32% -$443K 0.04% 140
2017
Q3 		$1.5M Buy
18,455
+519
+3% +$39.7K 0.06% 111
2017
Q2 		$1.27M Sell
17,936
-26,013
-59% -$1.73M 0.05% 117
2017
Q1 		$2.98M Sell
43,949
-65,189
-60% -$4.58M 0.13% 91
2016
Q4 		$7.82M Sell
109,138
-75,526
-41% -$5.61M 0.37% 76
2016
Q3 		$14.6M Sell
184,664
-33,509
-15% -$2.72M 0.71% 56
2016
Q2 		$18.2M Sell
218,173
-8,300
-4% -$737K 0.89% 50
2016
Q1 		$20.8M Buy
226,473
+22,270
+11% +$2.01M 1.06% 46
2015
Q4 		$20.7M Buy
204,203
+15,887
+8% +$1.65M 1.06% 45
2015
Q3 		$18.5M Buy
188,316
+26,250
+16% +$2.92M 0.99% 45
2015
Q2 		$19M Buy
162,066
+38,077
+31% +$4.16M 0.98% 45
2015
Q1 		$12.2M Buy
123,989
+76,676
+162% +$7.79M 0.64% 62
2014
Q4 		$4.46M Buy
47,313
+42,433
+870% +$4.39M 0.25% 79
2014
Q3 		$519K Buy
+4,880
New +$478K 0.03% 140
2014
Q1 		– Sell
-3,708
Closed -$278K – 188
2013
Q4 		$278K Buy
+3,708
New +$258K 0.02% 161

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

R.M. Davis Inc's GILD Position: Q2 2026 in Review

R.M. Davis Inc increased its Gilead Sciences (GILD) stake by 2.2% in Q2 2026, buying an estimated $6.32K and bringing the position to 2,222 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #250.

R.M. Davis Inc first reported a position in GILD in Q4 2013 and has held it in 26 quarters since. The position peaked at $20.8M in Q1 2016. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • R.M. Davis Inc held 2,222 shares of Gilead Sciences worth $281K as of Q2 2026.
  • R.M. Davis Inc bought 48 Gilead Sciences shares in Q2 2026, an estimated $6.32K.
  • Gilead Sciences made up ﹤0.01% of R.M. Davis Inc's portfolio in Q2 2026, its #250 holding.
  • R.M. Davis Inc first reported a position in Gilead Sciences in Q4 2013 and has held it in 26 quarters since.
  • R.M. Davis Inc's Gilead Sciences position peaked at $20.8M in Q1 2016.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.